Primary prevention studies and the healthy elderly: Evaluating barriers to recruitment

被引:27
作者
Boles, M
Getchell, WS
Feldman, G
McBride, R
Hart, RG
机构
[1] Kaiser Permanente, NW Div, PC Phys & Surg, NW Permanente, Portland, OR 97227 USA
[2] Axio Res Corp, Seattle, WA USA
[3] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA
关键词
elderly; aspirin; recruitment; primary prevention;
D O I
10.1023/A:1005153909429
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Although primary prevention studies are important tools in helping the healthy elderly stay healthy, recruiting from a community based cohort of healthy elderly individuals for a primary prevention study involves numerous barriers. To better identify and understand these barriers, we conducted and evaluated a comprehensive recruitment strategy for a primary prevention study testing aspirin in an HMO population. In the recruitment phase, we identified healthy individuals (65 years of age or older) who were members of a large, group-model HMO in Oregon and Washington, and used computerized medical database screening, statistical sampling, health plan mailings, e-mail communication with primary care providers, and the experience of a well-established research clinic in an effort to enroll health elderly in this primary prevention trial. Among a random sample of 47,453 eligible patients over the age of 65, 44% responded to recruitment efforts, but only 3% were enrolled-an overall yield of slightly less than 2%. To evaluate these results, we then conducted focus groups with 225 randomly selected "eligible refusers." We determined that healthy elders were hesitant to give up their choice to use aspirin, unwilling to travel to the research center, and reluctant to risk their tenuous hold on good health to participate in a study of primary prevention. Awareness of these attitudes is an indispensable step reward designing effective recruitment strategies for primary prevention studies involving the healthy elderly.
引用
收藏
页码:279 / 292
页数:14
相关论文
共 10 条
[1]   Recruiting older adults for clinical trials [J].
Adams, J ;
Silverman, M ;
Musa, D ;
Peele, P .
CONTROLLED CLINICAL TRIALS, 1997, 18 (01) :14-26
[2]   Clinical trials in the elderly - Should we do more? [J].
Cameron, HJ ;
Williams, BO .
DRUGS & AGING, 1996, 9 (05) :307-310
[3]   CLINICAL RESEARCH AND NON-INSTITUTIONAL ELDERLY - MODEL FOR SUBJECT RECRUITMENT [J].
LEADER, MA ;
NEUWIRTH, E .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1978, 26 (01) :27-31
[4]   Recruitment for controlled clinical trials: Literature summary and annotated bibliography [J].
Lovato, LC ;
Hill, K ;
Hertert, S ;
Hunninghake, DB ;
Probstfield, JL .
CONTROLLED CLINICAL TRIALS, 1997, 18 (04) :328-352
[5]   ASSESSING THE USE OF MEDICATIONS IN THE ELDERLY - METHODS AND INITIAL EXPERIENCE IN THE CARDIOVASCULAR HEALTH STUDY [J].
PSATY, BM ;
LEE, M ;
SAVAGE, PJ ;
RUTAN, GH ;
GERMAN, PS ;
LYLES, M .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :683-692
[6]   Clinical trial participant satisfaction: Survey of SHEP enrollees [J].
Schron, EB ;
WassertheilSmoller, S ;
Pressel, S .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (08) :934-938
[7]   COMPARISON OF RECRUITMENT STRATEGIES FOR A LARGE-SCALE CLINICAL-TRIAL IN THE ELDERLY [J].
SILAGY, CA ;
CAMPION, K ;
MCNEIL, JJ ;
WORSAM, B ;
DONNAN, GA ;
TONKIN, AM .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (10) :1105-1114
[8]   NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND DYSPEPSIA IN THE ELDERLY [J].
TALLEY, NJ ;
EVANS, JM ;
FLEMING, KC ;
HARMSEN, WS ;
ZINSMEISTER, AR ;
MELTON, LJ .
DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (06) :1345-1350
[9]   Mailing strategies and costs of recruiting heavy smokers in CARET, a large chemoprevention trial [J].
Valanis, B ;
Blank, J ;
Glass, A .
CONTROLLED CLINICAL TRIALS, 1998, 19 (01) :25-38
[10]   RECRUITMENT OF ELDERLY VOLUNTEERS FOR A MULTICENTER CLINICAL-TRIAL - THE SHEP PILOT-STUDY [J].
VOGT, TM ;
IRELAND, CC ;
BLACK, D ;
CAMEL, G ;
HUGHES, G .
CONTROLLED CLINICAL TRIALS, 1986, 7 (02) :118-133